John Owen Brennan - 02 Jun 2023 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Director
Signature
/s/ Jason Liljestrom, as Attorney-in-Fact
Issuer symbol
IBRX
Transactions as of
02 Jun 2023
Net transactions value
+$70,700
Form type
4
Filing time
05 Jun 2023, 19:55:59 UTC
Previous filing
15 Jun 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBRX Common Stock Purchase $13,700 +5,000 $2.74 5,000 02 Jun 2023 Direct
transaction IBRX Common Stock Purchase $28,000 +10,000 +200% $2.80 15,000 02 Jun 2023 Direct
transaction IBRX Common Stock Purchase $29,000 +10,000 +67% $2.90 25,000 02 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.